Cargando…

Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma

Renal cell carcinoma (RCC) is traditionally considered to be resistant to conventional low dose radiation therapy (RT). The emergence of image-guided stereotactic body radiation therapy (SBRT) made it possible to deliver much higher doses of radiation. Recent clinical trials of SBRT for RCC showed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolaev, Anatoly, Benda, Rashmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719793/
https://www.ncbi.nlm.nih.gov/pubmed/26793580
http://dx.doi.org/10.1016/j.eucr.2015.09.006
_version_ 1782410974478729216
author Nikolaev, Anatoly
Benda, Rashmi
author_facet Nikolaev, Anatoly
Benda, Rashmi
author_sort Nikolaev, Anatoly
collection PubMed
description Renal cell carcinoma (RCC) is traditionally considered to be resistant to conventional low dose radiation therapy (RT). The emergence of image-guided stereotactic body radiation therapy (SBRT) made it possible to deliver much higher doses of radiation. Recent clinical trials of SBRT for RCC showed improvement in local control rates and acceptable toxicity. Here we report a case of inoperable symptomatic RCC that was managed with SBRT. Strikingly, the presenting symptoms of gross hematuria and severe anemia were completely resolved following a course of SBRT. Thus, our case report highlights the potential benefit of this technique for patients with inoperable RCC.
format Online
Article
Text
id pubmed-4719793
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47197932016-01-20 Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma Nikolaev, Anatoly Benda, Rashmi Urol Case Rep Oncology Renal cell carcinoma (RCC) is traditionally considered to be resistant to conventional low dose radiation therapy (RT). The emergence of image-guided stereotactic body radiation therapy (SBRT) made it possible to deliver much higher doses of radiation. Recent clinical trials of SBRT for RCC showed improvement in local control rates and acceptable toxicity. Here we report a case of inoperable symptomatic RCC that was managed with SBRT. Strikingly, the presenting symptoms of gross hematuria and severe anemia were completely resolved following a course of SBRT. Thus, our case report highlights the potential benefit of this technique for patients with inoperable RCC. Elsevier 2015-10-17 /pmc/articles/PMC4719793/ /pubmed/26793580 http://dx.doi.org/10.1016/j.eucr.2015.09.006 Text en © 2016 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Nikolaev, Anatoly
Benda, Rashmi
Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma
title Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma
title_full Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma
title_fullStr Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma
title_full_unstemmed Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma
title_short Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma
title_sort palliative radiation therapy for symptomatic control of inoperable renal cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719793/
https://www.ncbi.nlm.nih.gov/pubmed/26793580
http://dx.doi.org/10.1016/j.eucr.2015.09.006
work_keys_str_mv AT nikolaevanatoly palliativeradiationtherapyforsymptomaticcontrolofinoperablerenalcellcarcinoma
AT bendarashmi palliativeradiationtherapyforsymptomaticcontrolofinoperablerenalcellcarcinoma